Recent Headlines
Within Biotechnology
NeuroMedix Poised to Realize Next Stage of Business Plan through Strategic Alliance or Acquisition
After very successful pre-clinical trials for its lead product ‘Minozac,’ Neuromedix is planning further work on this promising Alzheimer’s treatment. - December 01, 2006 - Neuromedix Inc.
New Technology Makes Performance Enhancing Drugs and Altitude Training Obsolete
Those seeking natural performance enhancement look to new technology that produces many of the same performance enhancing effects as steroids, EPO blood doping and high altitude / hypoxia training systems without the effort, cost or risks. - November 30, 2006 - EarthPulse Tech, LLC
Weekly Monitor Drug and Diagnostic Development in Neurodegenerative Diseases
HiTIS - life science & biotech intelligence, a European life sciences industry focused competitive intelligence firm, recently launched Neurodegenerative Diseases Therapeutics & Diagnostics Competitive Intelligence Weekly - November 30, 2006 - HiTIS - Life Science & Biotech Intelligence
Gamma Medica-Ideas Announces Agreement to Acquire and Merge Operations with Advanced Molecular Imaging
Los Angeles and Oslo based Gamma Medica Ideas, Inc. (GM-I), a leader in providing next-generation medical imaging devices for the pre-clinical and clinical markets, announced today that it had reached agreement to acquire and merge operations with Sherbrooke, Canada based Advanced Molecular... - November 28, 2006 - Gamma Medica-Ideas
HiTIS - Life Science & Biotech Intelligence Expands Web Presence with www.txpreview.com
HiTIS - life science & biotech intelligence, a European life sciences industry- focused competitive intelligence firm, has released its corporate website. - November 23, 2006 - HiTIS - Life Science & Biotech Intelligence
Put an Eye on the Weekly Electronic Publication Covering Drug and Device-Based Available Treatments, Current Research and Upcoming Therapies Addressing Eye Disorders
HiTIS - life science & biotech intelligence, a life sciences industry focused competitive intelligence firm, has released the 26th weekly issue of its Eye Care industry competitive intelligence publication: Eye Therapies Competitive Intelligence Weekly (ETCI Weekly). - November 20, 2006 - HiTIS - Life Science & Biotech Intelligence
"USP 797 Training Requirements: A Case Study," Detailing Experiences at Swedish Medical Center/Seattle, Now Posted on PublicRelationsNewsroom.com
"USP 797 Training Requirements: A Case Study" published by Baxa Corporation is now posted for media and professional access on PublicRelationsNewsroom.com. This paper summarizes the process used by Swedish Medical Center in Seattle, WA to comply with the personnel training and evaluation in aseptic manipulation skills required by the United States Pharmacopeia (USP) Chapter 797. - November 16, 2006 - Baxa Corporation
Cornerstone BioPharma, Inc. Obtains Exclusive Licensing Rights for Spectracef
Triangle-based specialty pharmaceutical company to serve $1.3 billion per year oral cephalosporin market - November 09, 2006 - Cornerstone BioPharma
Baxa Releases New 2 mL Exacta-Med® Dispenser for Oral Medication Delivery
New Exacta-Med Dispenser size provides another dosing option for oral liquid medications. Exacta-Med Oral Dispensers were the first syringes developed specifically for safe delivery of oral liquids. Baxa is the market leader for oral dispensing devices. - October 31, 2006 - Baxa Corporation
Researchers Validate Important New in Vivo Imaging Research Method for Studying Drug Efficiency and Disease Progression
Study Results Show that Accurate in Vivo Quantitation of Drug Distribution and Therapeutic Effect is Possible and Important - October 26, 2006 - Gamma Medica-Ideas
Reputed Orthopaedic Surgeon to Join Business Intelligence Services Firm HiTIS Team as Scientific and Medical Advisor
Life science industry-focused competitive intelligence services practice adds outstanding orthopaedics expertise to founding team to develop new competitive intelligence periodical reports. - October 17, 2006 - HiTIS - Life Science & Biotech Intelligence
Gamma Medica-Ideas Awarded Grant to Develop SPECT/MRI Imaging Instrument
Gamma Medica-Ideas (GM-I) has been awarded a $100,000 grant to develop a SPECT/MRI small animal imaging system. The grant is part of an $850,000 fast-track grant award from the National Institutes of Health’s National Institute of Biomedical Imaging and Bioengineering. Dr. Douglas... - October 05, 2006 - Gamma Medica-Ideas
Sleep is Most Important Factor in Achieving Peak Athletic Performance
Sleep is one of the most underestimated factors in athletic performance. Sleep deprived athletes have a reduced response time of up to 75% and fatigue related deficits can mean the difference between a medal or a loss. - September 25, 2006 - EarthPulse Tech, LLC
Baxa Corporation Signs Co-Marketing Agreement with Unit Dose Solutions Inc.
Denver-based Baxa Corporation announces the signing of an exclusive co-marketing agreement with Unit Dose Solutions Inc. of Morrisville, NC. Under the agreement, Baxa will market and sell the oral unit dose repackaging services provided by Unit Dose Solutions. UDS serves hospital and alternate-care providers by offering an outsourcing alternative for unit dose packaging and labeling. - September 22, 2006 - Baxa Corporation
Delivery Improvements of the AMD-drug Lucentis on the Way
The anti-VEGF Fab Lucentis is the new standard of care to treat AMD because it can improve visual acuity. Competitor drugs directed against the same and innovative targets are applied with non-intravitreal forms of administration to avoid the unease of intra-vitreal injection. - September 20, 2006 - La Merie Business Intelligence
InViragen Announces Exclusive Patent License Agreement with the Centers for Disease Control
InViragen, LLC, a biotechnology company dedicated to developing vaccines for emerging infectious diseases worldwide, has entered into an Exclusive Patent License Agreement with the Centers for Disease Control and Prevention (CDC). The licensed technology is applicable to vaccines against multiple viral diseases, including dengue fever and West Nile disease. Dengue fever threatens 2.5 billion people worldwide as well as travelers to tropical countries. - September 14, 2006 - Colorado BioScience Association
Baxa Corporation’s UK Subsidiary, Baxa Ltd, Announces Direct Sales and Marketing Operations In Austria
Baxa Ltd, subsidiary of Denver-based Baxa Corporation, has moved to a direct sales and marketing model for the Austrian market. The company provides systems and devices for simplifying the handling, mixing and administration of fluid medications. Direct operations will provide Baxa Ltd with improved customer access for product development and continuous improvement, while continuing their excellent customer service. - September 12, 2006 - Baxa Corporation
Biologics Define New Standard of Therapy in Psoriasis
Anti-TNF agents set the new gold standard of psoriasis treatment which could be outperformed by smarter next generation biologics and small molecules in safety and convenience. - September 08, 2006 - La Merie Business Intelligence
Leading Colorado Biotechnology and Medical Device Companies Selected to Present at BIO Mid-America VentureForum
Five Colorado-based companies have been selected to present at the Biotechnology Industry Organization (BIO) Mid-America VentureForum to be held September 25-27th at the InterContinental Hotel in Cleveland, Ohio. These companies are among more then 50 companies selected by venture capitalists from the nation’s leading firms who serve on BIO’s advisory board. - September 07, 2006 - Colorado BioScience Association
New Life Scientific Moves into New Headquarters
New Life Scientific, Inc (NWLS) a developmental biotech company whose core focus is to develop and commercialize novel biotech/pharmaceutical products including vaccines and stem cell based treatment modalities and to expand through our own research, collaborations, acquisitions and in-licensing,... - September 01, 2006 - New Life Scientific, Inc.
Gamma-Medica-Ideas Introduces New Tri-Modality FLEX Triumph™ Pre-Clinical Imaging System
Gamma Medica-Ideas (GM-I) will unveil its new FLEX Triumph™ tri-modality pre-clinical imaging system at the Society of Molecular Imaging’s annual meeting in Hawaii this week. FLEX Triumph is GM-I’s fifth generation pre-clinical imaging system. It can be configured with PET,... - August 31, 2006 - Gamma Medica-Ideas
ApopLogic Pharmaceuticals Wins the Second Annual Faegre & Benson Venture Showcase Award, Presented at BioWest 2006
ApopLogic Pharmaceuticals has won the second annual Faegre & Benson Venture Showcase Award at the BioWest 2006 conference in Denver. The announcement is made by Chris Shapard, bioscience director at the Colorado Office of Economic Development and International Trade (OEDIT), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards banquet held Thurs. evening at the Colo. Convention Center. - August 25, 2006 - Colorado BioScience Association
Baxa Opens Skills Training, Academics and Resources (STAR) Center for Pharmacy and Cleanroom Skills Training
Baxa Corporation is holding a ribbon-cutting ceremony today for a new, first-in-the-industry, strategic training center. The STAR Center offers pharmacy training for peak performance. First classes begin September 20th at the Englewood, Colo., location.. The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn. - August 23, 2006 - Baxa Corporation
Colorado BioScience Association Announces Winners of Its 2006 Awards Program, Honoring the Best of Colorado's Bioscience Industry
The Colorado BioScience Association (CBSA) has released winners of its 2006 Awards Program. Official presentation of the awards occurs Thursday evening, August 24, 6:30 – 8:30 p.m., at the CBSA’s annual awards banquet. Held in conjunction with the 2006 BioWest conference at the Colorado Convention Center, registration information is available at the 2006 BioWest Conference website. - August 18, 2006 - Colorado BioScience Association
The Crowded Field of VEGF and VEGF-R Targeting Drugs
The versatility of the vascular endothelial growth factor (VEGF) signalling pathway as a validated target and its excellent tractability explain a crowded field of drugs of all classes. - August 17, 2006 - La Merie Business Intelligence
Blue Sky Biotech, Inc Appoints Scott Gridley, Ph.D., as Senior Research Scientist
Blue Sky Biotech, Inc. announced the June 1st appointment of Scott Gridley, Ph.D., as Senior Research Scientist. Dr. Gridley previously worked for five years in the metabolic diseases division of Sandoz Research Institute (now Novartis Institutes for BioMedical Research) where he was involved in... - August 15, 2006 - Blue Sky Biotech, Inc.
Baxa Corporation’s Claude Hooton Featured in Leadership Strategy Book, Inside the Minds: The Health Care Management Team
Claude Hooton, Executive Vice President of Sales and Marketing for Baxa Corporation was recognized for his leadership through his contribution to the recently released book, Inside the Minds: The Health Care Management Team. Hooton’s contribution joins those of CEOs, CTOs and other leaders to provide insight into the best leadership practice in the health care industry. - August 11, 2006 - Baxa Corporation
Baxa Corporation Releases Abacus™ v2 Order Entry and Calculation Software for TPN
The new version of Abacus, the specialized Baxa software for managing orders and calculations for total parenteral nutrition, is now available. The Windows-based system is the industry-leading program for automated compounding. Designed by health-system pharmacists, Abacus v2 ensures safety and reduces the opportunity for user error in the prescribing, calculating and mixing of multi-source compounds. - August 09, 2006 - Baxa Corporation
Baxa Corporation Selected as Second-Place Winner for Best Company to Work For in Colorado
In a ceremony held today in Westminster, Colorado – Englewood-based Baxa Corporation was selected in second place for best large company to work for in Colorado. Candidate choice followed finalist selection based on employee surveys by the Society for Human Resource Management. - August 03, 2006 - Baxa Corporation
A Full Pipeline of Follow-on TNF-Antagonists
The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds including improved TNF-antagonists and molecules originating from new technologies. - August 02, 2006 - La Merie Business Intelligence
Five Top Colorado Bioscience Company CEOs Present at This Year’s BioWest Investor Forum
CEOs from five of Colorado’s top bioscience companies will present at the BioWest 2006 Investor Forum on August 24th – registration is still open for the two-day BioWest event, which is the Rocky Mountain Region’s premier bioscience conference and expo. CEOs featured in the Investor Forum include Paul Berns, Allos Therapeutics; John Serino, Encision; Bill Freytag, Myogen; Patrick Mahaffy, Pharmion; and Ken Collins, Replidyne. - July 28, 2006 - Colorado BioScience Association
CytoCore, Inc. Announces New Cancer Screening and Treatment System on the Horizon
CytoCore, Inc., a biomolecular diagnostics screening company committed to bringing new cancer solutions to the market, has announced the development of a new screening and treatment system. CytoCore has developed the InPath™ System, a cervical/uterine cancer screening and treatment system... - July 24, 2006 - CytoCore
Baxa Corporation Named One of 25 Best Companies to Work for in Colorado
Englewood-based Baxa Corporation has been selected one of the 25 best companies to work for in Colorado following employee surveys by the Society for Human Resource Management (SHRM). The recognition is a result of the responses received from an electronic survey sent to most of the company’s Colorado-based associates in April. The Best Companies initiative honors Colorado companies that show dedication to their employees’ growth and quality of life. - July 21, 2006 - Baxa Corporation
Baxa Selected One of 50 ‘Companies to Watch’ in the Medical Device Industry
Medical Device and Diagnostic Industry (MD&DI) magazine has selected Colorado-based Baxa Corporation as a notable company in its review of medical device manufacturers and their contributions The magazine chose companies with formidable track records or the potential for success, and technology breakthroughs or transformations of standards of care that its editors feel are worth monitoring. This is the first year that Baxa has won this designation. - July 14, 2006 - Baxa Corporation
Seven Finalists Selected for The BioWest 2006 Venture Showcase Competition, Presenting World-Changing Technologies
Novel cancer drugs; innovative treatments for blood cancers and clotting; new ways to attack inflammatory and infectious diseases; ground-breaking compounds to treat osteoporosis and metastatic bone disease; pioneering devices for orthopedic surgery; commercializing biofuels from algae; and revolutionary wearable rehabilitation systems comprise the seven finalists in this year’s BioWest Veture Showcase competition. - July 11, 2006 - Colorado BioScience Association
Electronic Sleep Aid Provides Unparalleled Athletic Performance Enhancement
EarthPulse™ enhances athletic performance in world class and amateur competitors safely and more effectively than anabolic steroids or blood doping, while significantly improving their sleep. - July 09, 2006 - EarthPulse Tech, LLC
CytoCore Retains MMI Associates, Inc.
Raleigh PR firm to provide public relations and product marketing services to Uterine and Cervical Cancer screening firm. - July 08, 2006 - CytoCore
New ValiMed™ Medication Validation System Demonstrates USP 797 Compliance at ASHP Summer Meeting
Baxa Corporation demonstrates the next-generation ValiMed System for medication safety at booth no. 729 at the American Society of Health-System Pharmacists Summer Meeting June 25 – 28 in Orlando, Fla. The next-generation ValiMed Technology offers the same benefits as the original system, with additional reporting features and a smaller sample requirement. - June 26, 2006 - Baxa Corporation
Baxa Ltd Launches New CyTwo-Fer™ Needle for Safe Drug Reconstitution and Transfer
Baxa introduces a new 4 mm version of its CyTwo-Fer Needle. The unique dual-purpose device permits vented and non-vented use for vial reconstitution and withdrawal from drug vials and bags. - June 26, 2006 - Baxa Corporation
Baxa to Launch STAR Center for Professional Pharmacy and Cleanroom Training at ASHP Annual Meeting
Baxa Corporation will announce the development of a professional Skills Training, Academics and Resources (STAR) Center for pharmacy and cleanroom skills training at the Annual Meeting of the American Society of Health-System Pharmacists in Orlando, Florida. The STAR Center, a state-of-the-art facility designed for cleanroom and pharmacy practice demonstration, is located at the company’s world headquarters south of Denver, Colorado. - June 23, 2006 - Baxa Corporation
Tuberculosis and Air Travel - Free Webinar on July 24th
Healthcare professional, Stacey Lloyd, is offering a free webinar to discuss the risks of contracting tuberculosis during air travel at www.StaceyLloyd.com. This webinar will be available to air travelers and healthcare personnel during the busy travel season. - June 20, 2006 - Pharmaceutical Resources Group
Biogenerics and New Technologies Compete with 1st Generation Major Products
The US$ 32 bln market of six major protein products is enfacing competition by less costly biogenerics and by improved products via drug delivery or protein engineering technologies and even oral, small molecule solutions. - June 20, 2006 - La Merie Business Intelligence
Baxa Launches New 35 mL Exacta-Med® Oral Dispenser
New size of Exacta-Med® Oral Dispenser completes the product range – from 0.5 to 60 mL – of safe oral medication dispensers for market leader Baxa Corporation. Exacta-Med Oral Dispensers play a vital role in preventing wrong-route administration of non-IV fluid drugs. Their unique dispenser tip cannot connect to a luer needle hub or a needleless IV system. - June 13, 2006 - Baxa Corporation
Baxter Black and Ira Flatow Lead the Lineup of Presenters for Biowest 2006, Now Open for Registration
Registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2006. More than 750 participants are expected at this year’s event, August 23-24, at the Colorado Convention Center in Denver. America’s “Cowboy Poet” Baxter Black and NPR Science Friday® host Ira Flatow are the headliners for Biowest 2006, along with the presentation, “Where Innovation Happens” from Federal Reserve Executive Michael Orlando. - June 06, 2006 - Colorado BioScience Association
Cornerstone BioPharma, Inc. and Athlon Pharmaceuticals Sign Co-Promotion Agreement
Cornerstone BioPharma™, the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the respiratory arena, today announced the company has signed a co-promotion agreement with Athlon Pharmaceuticals... - June 06, 2006 - Cornerstone BioPharma
AnaSpec Introduces New Line of Reagents and Kits for Study of Protein Phosphorylation
AnaSpec, a leading provider of integrated proteomics solutions, has introduced an extensive new line of reagents and kits for the study of protein phosphorylation. Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that serves to modify the activity of the... - June 06, 2006 - AnaSpec, EGT Group
Baxa Corporation Wins Two AMA Awards
At the Colorado American Marketing Association PEAK Awards ceremony, Baxa Corporation won the Gold Award for Direct Mail Campaign and the Annual Marketer of the Year Award. The direct mail award recognized the success of the company’s Real Pharmacy campaign, developed to generate customer testimonials for Baxa products. Marian Robinson, VP of Marketing for Baxa Corporation was recognized as Annual Marketer of the Year (AMY) for exemplifying outstanding marketing leadership and accomplishment. - June 05, 2006 - Baxa Corporation
Imminent Launches of New EPO Products and Consolidation of the Biogenerics Field
The Business Intelligence firm La Merie S.L. reported today changes in the field of erythropoiesis stimulating agents (ESA) observed in a follow-up analysis. The first launch of a new ESA in Europe is expected to be Shire’s epoetin omega in the first half of 2007 to be followed by... - June 03, 2006 - La Merie Business Intelligence
Localized Delivery of PDE-4 Inhibitors to Open the Therapeutic Window
The Localized delivery of phosphodiesterase-4 (PDE-4) inhibitors appears to be short term solution to overcome the dose-limiting side effects of severe nausea and emesis occurring after oral administration. In the long-term, subtype-selective PDE-4 inhibitors and combination regimens may help to improve the therapeutic index. - May 31, 2006 - La Merie Business Intelligence
WellAware™ Error-Free Light Guided Manual Pipetting System is Now Application Based
BioTX has finished the development of an application based, light guided manual pipetting system called WellAware which is ideal for forensic, paternity, life science, pharmaceutical, preclinical and chemistry labs. WellAware provides lab managers with an inexpensive alternative or supplement to full automation. WellAware is configured right out of the box for PCR, DNA sequencing, genotyping, microplate transpositions, dilutions, normalizations, microplate reformatting and cherry-picking. - May 25, 2006 - BioTX Automation, Inc.